{{Rsnum
|rsid=12039904
|Gene=LOC100506023
|Chromosome=1
|position=173243134
|Orientation=plus
|GMAF=0.1933
|Gene_s=IGHVII-15-1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 61.3 | 33.9 | 4.8
| HCB | 58.1 | 37.2 | 4.7
| JPT | 57.8 | 35.6 | 6.7
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 58.1 | 37.2 | 4.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19092840
|Title=Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus
|OA=1
}}

{{PMID Auto
|PMID=22422496
|Title=Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis
|OA=1
}}

{{PMID|19778912|OA=1
}} Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.

{{PMID|21187296}} A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.

{{PMID Auto
|PMID=22870213
|Title=Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}